Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

By Treanor J.J.   Kotloff K.   Betts R.F.   Belshe R.   Newman F.   Iacuzio D.   Wittes J.   Bryant M.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 899-906

Elsevier

Access to resources Recommend Favorite

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study

By Gorse G.J.   O'Connor T.Z.   Young S.L.   Mendelman P.M.   Bradley S.F.   Nichol K.L.   Strickland J.H.   Paulson D.M.   Rice K.L.   Foster R.A.   Fulambarker A.M.   Shigeoka J.W.   Kuschner W.G.   Goodman R.P.   Neuzil K.M.   Wittes J.   Boardman K.D.   Peduzzi P.N.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2142-2153

Elsevier

Access to resources Recommend Favorite

Cold-attenuated live influenza vaccines, a risk-benefit assessment

By Pfleiderer M.   Lower J.   Kurth R.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 886-894

Elsevier

Access to resources Recommend Favorite

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy - A meta-analysis

By Beyer W.E.P.   Palache A.M.   de Jong J.C.   Osterhaus A.D.M.E.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1340-1353

Elsevier

Access to resources Recommend Favorite

Live attenuated influenza virus vaccines: new options for the prevention of influenza

By Nichol K.L.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4373-4377

Elsevier

Access to resources Recommend Favorite